Pharmacy
News
Rivaroxaban monitoring kit launched in Europe
Instrumentation Laboratory, a company that develops in vitro diagnostic instruments, has announced the commercialization of the HemosIL...
News
NICE recommends edoxaban for NVAF
Photo courtesy of the CDC The UK’s National Institute for Health and Care Excellence (NICE) has issued a draft guidance recommending the oral...
News
FDA approves IVIG product for kids
Photo by Bill Branson The US Food and Drug Administration (FDA) has approved an intravenous human immune globulin (IVIG) product (Gammaplex) for...
News
Drug on fast track to treat aHUS
Image by Kevin MacKenzie The US Food and Drug Administration (FDA) has granted fast track designation to OMS721 for the treatment of atypical...
News
FDA grants drug orphan designation for ITP
Photo by Linda Bartlett The US Food and Drug Administration (FDA) has granted orphan designation to veltuzumab for the treatment of immune...
News
Drug gets orphan designation for CTCL
The European Commission has granted orphan drug designation to synthetic hypericin, the active pharmaceutical ingredient in SGX301, for the...
News
Health Canada grants drug conditional approval for MCL
Photo courtesy of Janssen Biotech, Inc. Health Canada has granted conditional approval for the BTK inhibitor ibrutinib (Imbruvica) to treat...
News
FDA warns of anticoagulant/antidepressant mix-up
Photo courtesy of AstraZeneca The US Food and Drug Administration (FDA) has announced that confusion between the anticoagulant Brilinta (...
News
Study suggests hemophilia therapies are too costly
Hemophilia therapies account for the largest portion of pharmacy expenditures among publicly insured children with serious chronic illnesses in...
News
CHMP recommends drug for acquired hemophilia A
Photo courtesy of Baxter International Inc. The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended...
News
Some AEs not reported according to regulations
Photo courtesy of the FDA A new study indicates that drug manufacturers fail to report about 10% of serious and unexpected adverse events (AEs)...